Crossmark

PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer

Published Online: 2021-01-06

Published Print: 2021-12

Authors

Li, Zheng https://orcid.org/0000-0002-9828-5475
Li, Yaming

Wang, Xiaolong

Yang, Qifeng
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 81672613)

National Natural Science Foundation of China (No. 81874119)

National Natural Science Foundation of China (No. 82072912)

Taishan Scholar Foundation of Shandong Province (No. ts20190971)
License Information

Text and Data Mining valid from 2021-01-06

Version of Record valid from 2021-01-06
More Information

Article History

Received: 29 August 2020

Accepted: 7 December 2020

First Online: 6 January 2021

Ethics approval and consent to participate

: This study was approved by the Ethics Committee on Scientific Research of Qilu Hospital, Shandong University.

: Not applicable.

: No potential conflict of interest was reported by the authors.

Document is current